2.3316
03-九月-25 11:11:27
15 分钟延时
股票
+0.1216
+5.50%
今日范围
2.1000 - 2.3316
ISIN
N/A
来源
NASDAQ
Lisata Therapeutics’ Director and Scientific Founder of the CendR Platform™ Technology, Erkki Ruoslahti, M.D., Ph.D., Receives 2022 Albert Lasker Basic Medical Research Award
29 9月 2022 05:00:01 条件 Nasdaq GlobeNewswire